1. Home
  2. IKNA vs PMEC Comparison

IKNA vs PMEC Comparison

Compare IKNA & PMEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKNA
  • PMEC
  • Stock Information
  • Founded
  • IKNA 2016
  • PMEC 1984
  • Country
  • IKNA United States
  • PMEC Singapore
  • Employees
  • IKNA N/A
  • PMEC N/A
  • Industry
  • IKNA Biotechnology: Pharmaceutical Preparations
  • PMEC
  • Sector
  • IKNA Health Care
  • PMEC
  • Exchange
  • IKNA Nasdaq
  • PMEC Nasdaq
  • Market Cap
  • IKNA 63.7M
  • PMEC 58.4M
  • IPO Year
  • IKNA 2021
  • PMEC 2023
  • Fundamental
  • Price
  • IKNA $1.43
  • PMEC $1.47
  • Analyst Decision
  • IKNA Buy
  • PMEC
  • Analyst Count
  • IKNA 2
  • PMEC 0
  • Target Price
  • IKNA $13.50
  • PMEC N/A
  • AVG Volume (30 Days)
  • IKNA 434.6K
  • PMEC 56.0K
  • Earning Date
  • IKNA 07-24-2025
  • PMEC 01-01-0001
  • Dividend Yield
  • IKNA N/A
  • PMEC N/A
  • EPS Growth
  • IKNA N/A
  • PMEC N/A
  • EPS
  • IKNA N/A
  • PMEC N/A
  • Revenue
  • IKNA N/A
  • PMEC $74,349,000.00
  • Revenue This Year
  • IKNA N/A
  • PMEC N/A
  • Revenue Next Year
  • IKNA N/A
  • PMEC N/A
  • P/E Ratio
  • IKNA N/A
  • PMEC N/A
  • Revenue Growth
  • IKNA N/A
  • PMEC 3.94
  • 52 Week Low
  • IKNA $0.97
  • PMEC $0.49
  • 52 Week High
  • IKNA $1.94
  • PMEC $1.65
  • Technical
  • Relative Strength Index (RSI)
  • IKNA 59.83
  • PMEC 53.48
  • Support Level
  • IKNA $1.20
  • PMEC $1.42
  • Resistance Level
  • IKNA $1.42
  • PMEC $1.61
  • Average True Range (ATR)
  • IKNA 0.08
  • PMEC 0.09
  • MACD
  • IKNA 0.00
  • PMEC -0.02
  • Stochastic Oscillator
  • IKNA 82.26
  • PMEC 36.36

About IKNA Ikena Oncology Inc.

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.

About PMEC Primech Holdings Ltd.

Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.

Share on Social Networks: